Results 61 to 70 of about 28,581 (233)

Heterologous prime-boost immunization co-targeting dual antigens inhibit tumor growth and relapse

open access: yesOncoImmunology, 2020
Therapeutic cancer vaccines aim to induce an effective immune response against cancer, and the effectiveness of these vaccines is influenced by the choice of immunogen, vaccine type, and immunization strategy.
Qianqian Guo   +14 more
doaj   +1 more source

Mouse cell lines transfected with human MUC1 DNA express MUC1-ARF.

open access: yes, 2016
(A, and C) DA3 cells transfected with MUC1 cDNA; (B) DA3 cells transfected with human MUC1 genomic DNA, and (D) non-transfected mouse parental DA3 cells were immunostained with anti MUC1-ARF monoclonal antibody MPR2G10 followed by red-labeled secondary ...
John Hilkens (412442)   +12 more
core   +1 more source

Exploring Programmed Cell Death-Related Biomarkers and Disease Therapy Strategy in Nasopharyngeal Carcinoma Using Transcriptomics

open access: yesFrontiers in Bioscience-Landmark
Background: Uncontrolled cellular proliferation may result in the progression of diseases such as cancer that promote organism death. Programmed cell death (PCD) is an important mechanism that ensures the quality and quantity of cells, which could be ...
Jiangyu Yan   +3 more
doaj   +1 more source

Differential expression of the glycosylated forms of MUC1 during lung development

open access: yesEuropean Journal of Histochemistry, 2009
Human MUC1 mucin is a high-molecular weight transmembrane glycoprotein expressed on the apical surface of the simple epithelia of many different tissues.
J Sakurai   +6 more
doaj   +1 more source

Enhancing T Cell and Antibody Response in Mucin-1 Transgenic Mice through Co-Delivery of Tumor-Associated Mucin-1 Antigen and TLR Agonists in C3-Liposomes

open access: yesPharmaceutics, 2023
Mucin-1 (MUC1) is a highly relevant antigen for cancer vaccination due to its overexpression and hypo-glycosylation in a high percentage of carcinomas. To enhance the immune response to MUC1, our group has developed C3-liposomes that encapsulate the MUC1
Ameneh Arabi   +5 more
doaj   +1 more source

Illuminating point‐of‐care diagnostics with aggregation‐induced emission biosensors

open access: yesFlexMat, EarlyView.
This review highlights the application of aggregation‐induced emission luminogens (AIEgens) in point‐of‐care (POC) diagnostics for disease biomarker detection. It systematically examines a range of biosensing platforms, including lateral flow immunoassays, microfluidic chips, and electrochemiluminescence sensors, alongside their utility in detecting ...
Danni Hu   +3 more
wiley   +1 more source

Comparison of Stress‐Mediated Vocal Fold Epithelial Effects in Conventionally‐Raised and Germ‐Free Mice

open access: yesThe Laryngoscope, EarlyView.
The overarching aim of our study is to compare vocal fold epithelial changes in conventionally raised and germ‐free mice allotted to stressed and control groups. ABSTRACT Introduction Up to 25% of patients with voice disorders report concurrent psychosocial stress, which has been shown to cause laryngeal microbiome dysbiosis.
Anumitha Venkatraman   +2 more
wiley   +1 more source

MUC1 Makes Me Miserable [PDF]

open access: yesJournal of the American Society of Nephrology, 2018
Monogenic diseases make an important contribution to the overall burden of kidney disease– accounting for well in excess of 10% of people needing renal replacement therapy. In this setting an accurate diagnosis is advantageous because it can provide prognostic information for the patient ...
Daniel P. Gale, Robert Kleta
openaire   +3 more sources

Analysis of Carbohydrates and Glycoconjugates by Matrix‐Assisted Laser Desorption/Ionization Mass Spectrometry: An Update for 2023–2024

open access: yesMass Spectrometry Reviews, EarlyView.
ABSTRACT The use of MALDI mass spectrometry for the analysis of carbohydrates and glycoconjugates is a well‐established technique and this comprehensive review is the twelfth update of the original article published in 1999 and brings coverage of the literature to the end of 2024.
David J. Harvey
wiley   +1 more source

Supplemental Figure 2: Characterization of MUC1-DG75 transfectant cell line and of the MUC1-DG75-MVs. from Microvesicle Cargo of Tumor-Associated MUC1 to Dendritic Cells Allows Cross-presentation and Specific Carbohydrate Processing

open access: yes, 2014
A, MUC1 glycoform expression of MUC1-DG75 transfectant detected by flow cytometry employing anti-MUC1 glycoform specific MoAbs. Only the ST-MUC1 glycoform, (MoAb MYE12), is expressed on the surface of transfectant cells.
Morena Antonilli (15111665)   +12 more
core   +1 more source

Home - About - Disclaimer - Privacy